NASDAQ:ADUS - Addus Homecare Stock Price, Forecast & News

Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."

Addus Homecare Co. (NASDAQ:ADUS) issued its earnings results on Monday, November, 4th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.49 by $0.13. The firm had revenue of $169.80 million for the quarter, compared to analysts' expectations of $160.25 million. Addus Homecare had a return on equity of 8.00% and a net margin of 3.35%. The company's revenue for the quarter was up 23.3% on a year-over-year basis. View Addus Homecare's Earnings History.

Addus Homecare is scheduled to release their next quarterly earnings announcement on Monday, March 2nd 2020. View Earnings Estimates for Addus Homecare.

8 brokerages have issued 12-month price targets for Addus Homecare's shares. Their forecasts range from $75.00 to $115.00. On average, they expect Addus Homecare's stock price to reach $96.29 in the next year. This suggests that the stock has a possible downside of 1.1%. View Analyst Price Targets for Addus Homecare.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Addus Homecare.

Press coverage about ADUS stock has trended positive on Sunday, InfoTrie reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Addus Homecare earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Addus Homecare.

Addus Homecare saw a decline in short interest in December. As of December 13th, there was short interest totalling 618,600 shares, a decline of 12.5% from the November 28th total of 707,200 shares. Based on an average daily volume of 161,400 shares, the short-interest ratio is currently 3.8 days. Currently, 4.8% of the company's stock are short sold. View Addus Homecare's Current Options Chain.

Some companies that are related to Addus Homecare include Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), BioScrip (BIOS) and New York Health Care (BBAL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus Homecare investors own include Align Technology (ALGN), Activision Blizzard (ATVI), Celgene (CELG), Cisco Systems (CSCO), Incyte (INCY), Ulta Beauty (ULTA), AbbVie (ABBV), Bank of America (BAC), salesforce.com (CRM) and Nike (NKE).

Addus Homecare's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Calamos Advisors LLC (0.53%), State of Alaska Department of Revenue (0.07%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, David W Tucker, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Institutional Ownership Trends for Addus Homecare.

ADUS stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC and Louisiana State Employees Retirement System. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Insider Buying and Selling for Addus Homecare.

ADUS stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View Insider Buying and Selling for Addus Homecare.

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ADUS stock can currently be purchased for approximately $97.40.

Addus Homecare has a market capitalization of $1.52 billion and generates $518.12 million in revenue each year. The company earns $17.50 million in net income (profit) each year or $1.69 on an earnings per share basis. Addus Homecare employs 33,153 workers across the globe.View Additional Information About Addus Homecare.

The official website for Addus Homecare is http://www.addus.com/.

Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]